A Study of Quintuple Therapy to Treat COVID-19 Infection
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 60
Summary
- Conditions
- Corona Virus Infection
- Coronavirus 19
- COVID-19
- SARS COV2
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: This is a Randomized, Double-Blind, Placebo-Controlled Phase II interventional StudyMasking: Double (Participant, Investigator)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
In this study patients will be treated with a combination therapy to determine if this combination can effectively treat COVID-19. Treatment will last ten days. The study will last 24 weeks.
In this study patients will be treated with a combination therapy to determine if this combination can effectively treat COVID-19. Treatment will last ten days. The study will last 24 weeks.
Tracking Information
- NCT #
- NCT04334512
- Collaborators
- DSCS CRO
- Investigators
- Principal Investigator: Sabine Hazan, MD ProgenaBiome
Get Well Soon